FDA green lights 2nd booster of Pfizer, Moderna COVID shots for older Americans
Posted on AllSides March 29th, 2022
From The Center
REUTERS/Emily Elconin
The U.S. Food and Drug Administration on Tuesday authorized a second booster dose for people age 50 and older of the two most commonly used COVID-19 vaccines, citing data showing waning immunity and the risks posed by Omicron variants of the virus.
Reporting by Michael Erman in New Jersey and Manojna Maddipatla in Bangaluru, Additional reporting by Ahmed Aboulenein in Washington; Editing by Bill Berkrot
